Curaizon is a UK based health company with its offices throughout Europe. It was founded with an idea and an aim of helping the patients take their medication correctly which can save lives and reduce healthcare costs. Due to irregular medicines, thousands of people die, and billion dollars are wasted around. The company provides a complete health care programme that is designed to improve drug adherence among the patients. This programme can avoid the massive cost of medication.
The company has come up with the programme to help people with the technological advancements. About a report published by the World Health Organisation, only about 50% people throughout the developed countries take their medication the company has launched CuraServe™ which acts as a platform to ensure that customers receive the drug as required. The cost of treatment provided to a patient with low adherence is twice that of a patient with high adhesion. To tackle this problem Curaizon combined a series of tools and messages, supported by predictive analytics to increase the rate of drug adherence.
CuraServe is a technology that has been developed by the Curaizon. National health services deploy CuraServe to their patients which helps and ensure parents to take the proper medicine at required intervals. The comprehensive set of patient notifications and reminders with integration into the system assists in lowering the health care cost and save many lives. CuraServe also incorporates a big-data driven solution made to be used in advance medical research.
The Solution works with the patients, their families, and healthcare professionals. Curaizon uses the most practical, fastest and economically viable means of a communication system for securing the high levels of adherence to prescriptions. Coraizon aims in targeting the countries with national health services and currently the company is serving around 1.4 billion customers worldwide.
Data shows that up to 98% of patients are comfortable sharing their health-related data when they know the purpose of the collection is research and development in the field of healthcare services. The data can directly benefit them through the advancements and innovation. The data of the programme provides many benefits to the society which leads to the high demand for data by the pharmaceutical companies and biotech researchers.
The data can be access by the pharmaceutical companies, researchers or academics only by joining Curaizon's initial Coin Offering(ICO) and then purchasing CuraTokens. CuraTokens is an ERC-209 Ethereum-based utility token which is used to access medical adherence. Moreover, Curaizon uses blockchain technology to manage authentication and accountability by allowing individuals to back in control of their data.
Curaizon had tied-up with almost five essential companies for their technological advancements programme and innovation. The best in the line of Board of advisory helps the company to take first steps towards the change and towards serving people by reducing their costs on health issues, and to live a healthy life. Curaizon believes also believes in helping the society and to have social responsibility at the top for which company has decided to share the 10% of the profits with the Curacharity through fiat currency which will be paid to the charities further.
Official links for more details,
Website: https://curatoken.curaizon.com/
Twitter: https://twitter.com/curaizon
Telegram: https://t.me/joinchat/ILiK_Q7VBLOByz_7mMUgsQ
Ann Thread: https://bitcointalk.org/index.php?topic=4401662.0
Facebook: https://www.facebook.com/curaizonltd/
Thank you for reading my blog.
Published by cryptohipo
My profile: https://bitcointalk.org/index.php?action=profile;u=1464627
My ETH Wallet: 0xacADB2bEd1aA3DdF8390641378E2A6c91B0d33CA
